DE69926616D1 - Verwendung von reboxetine zur behandlung neuropsychiatrischer beschwerden - Google Patents

Verwendung von reboxetine zur behandlung neuropsychiatrischer beschwerden

Info

Publication number
DE69926616D1
DE69926616D1 DE69926616T DE69926616T DE69926616D1 DE 69926616 D1 DE69926616 D1 DE 69926616D1 DE 69926616 T DE69926616 T DE 69926616T DE 69926616 T DE69926616 T DE 69926616T DE 69926616 D1 DE69926616 D1 DE 69926616D1
Authority
DE
Germany
Prior art keywords
disorders
reboxetine
treatment
addiction
neuropsychiatric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69926616T
Other languages
English (en)
Other versions
DE69926616T2 (de
Inventor
Fred Hassan
Michael Mccall
Paul Taylor
Voigtlander F Von
Ho Wong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co LLC
Original Assignee
Pharmacia and Upjohn Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co LLC filed Critical Pharmacia and Upjohn Co LLC
Publication of DE69926616D1 publication Critical patent/DE69926616D1/de
Application granted granted Critical
Publication of DE69926616T2 publication Critical patent/DE69926616T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Addiction (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
DE69926616T 1998-04-09 1999-04-02 Verwendung von reboxetine zur behandlung neuropsychiatrischer beschwerden Expired - Fee Related DE69926616T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8123198P 1998-04-09 1998-04-09
US81231P 1998-04-09
PCT/US1999/004289 WO1999052531A1 (en) 1998-04-09 1999-04-02 New treatments for nervous disorders

Publications (2)

Publication Number Publication Date
DE69926616D1 true DE69926616D1 (de) 2005-09-15
DE69926616T2 DE69926616T2 (de) 2006-05-24

Family

ID=22162900

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69926616T Expired - Fee Related DE69926616T2 (de) 1998-04-09 1999-04-02 Verwendung von reboxetine zur behandlung neuropsychiatrischer beschwerden

Country Status (24)

Country Link
US (1) US6352986B1 (de)
EP (1) EP1069900B1 (de)
JP (1) JP2002511414A (de)
KR (1) KR20010034758A (de)
CN (1) CN1301164A (de)
AT (1) ATE301462T1 (de)
AU (1) AU756373B2 (de)
BR (1) BR9909478A (de)
CA (2) CA2321157A1 (de)
CZ (1) CZ297346B6 (de)
DE (1) DE69926616T2 (de)
DK (1) DK1069900T3 (de)
EA (1) EA200001049A1 (de)
ES (1) ES2244189T3 (de)
HU (1) HUP0102436A3 (de)
IL (1) IL138855A0 (de)
NO (1) NO20005059D0 (de)
NZ (1) NZ507398A (de)
PL (1) PL193797B1 (de)
PT (1) PT1069900E (de)
SK (1) SK14492000A3 (de)
TR (1) TR200002868T2 (de)
WO (1) WO1999052531A1 (de)
ZA (1) ZA200004454B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586427B2 (en) 1998-04-09 2003-07-01 Pharmacia & Upjohn Company Treatments for nervous disorders
DK1493442T3 (da) * 1999-07-01 2005-12-19 Pharmacia & Upjohn Co Llc Reboxetin til behandling af perifer neuropati
CN1660108A (zh) * 1999-07-01 2005-08-31 法玛西雅厄普约翰美国公司 高度选择性去甲肾上腺素再摄取抑制剂及其用途
JP2003525899A (ja) * 2000-03-07 2003-09-02 イーライ・リリー・アンド・カンパニー 乾癬の治療
SE521512C2 (sv) 2001-06-25 2003-11-11 Niconovum Ab Anordning för administrering av en substans till främre delen av en individs munhåla
US20040102440A1 (en) * 2002-07-01 2004-05-27 Wong Erik Ho Fong Method of promoting smoking cessation
EP1578422B1 (de) 2002-12-20 2007-04-11 NicoNovum AB Chemisch und physikalisch stabiles teilchenförmiges material enthaltend nikotin und microcrystalline cellulose
GEP20125566B (en) 2005-07-15 2012-07-10 Amr Technology Inc Aryl-and heteroaryl-substituded tetrahydro-benzazepines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
US9402809B2 (en) 2006-03-16 2016-08-02 Niconovum Usa, Inc. Snuff composition
US20100069389A1 (en) * 2008-09-06 2010-03-18 Bionevia Pharmaceuticals, Inc. Novel forms of reboxetine
SG175420A1 (en) 2009-05-12 2011-12-29 Albany Molecular Res Inc 7-([1,2,4,]triazolo[1,5,-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4- tetrahydroisoquinoline and use thereof
JP5739415B2 (ja) 2009-05-12 2015-06-24 ブリストル−マイヤーズ スクウィブ カンパニー （Ｓ）−７−（［１，２，４］トリアゾロ［１，５−ａ］ピリジン−６−イル）−４−（３，４−ジクロロフェニル）−１，２，３，４−テトラヒドロイソキノリンの結晶形態およびその使用
EP2606049A4 (de) 2010-08-17 2014-01-08 Albany Molecular Res Inc 2,5-methan- und 2,5-ethan-tetrahydrobenzazepin-derivate und ihre verwendung zur hemmung der wiederaufnahme von norepinephrin, dopamin und serotonin

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL56369A (en) 1978-01-20 1984-05-31 Erba Farmitalia Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
EP0072177B1 (de) * 1981-08-07 1987-01-07 Holset Engineering Company Limited Rotor für Zentrifugalkompressor
GB8419683D0 (en) 1984-08-02 1984-09-05 Erba Farmitalia 3-substituted derivatives of 1-amino-2-hydroxy-propane
US5281624A (en) * 1991-09-27 1994-01-25 Eli Lilly And Company N-alkyl-3-phenyl-3-(2-substituted phenoxy) propylamines and pharmaceutical use thereof
ZA958725B (en) * 1994-10-20 1997-04-16 Lilly Co Eli Treatment of disorders with duloxetine
US5658590A (en) * 1995-01-11 1997-08-19 Eli Lilly And Company Treatment of attention-deficit/hyperactivity disorder
KR19990035817A (ko) * 1995-07-24 1999-05-25 피터 지. 스트링거 주의력 결핍증/활동항진증의 치료 방법
JP2001517628A (ja) * 1997-09-23 2001-10-09 イーライ・リリー・アンド・カンパニー 注意欠陥／多動障害の治療法
UA56257C2 (uk) 1997-09-23 2003-05-15 Елі Ліллі Енд Компані Спосіб лікування неадекватної визивної поведінки

Also Published As

Publication number Publication date
PL346293A1 (en) 2002-01-28
HUP0102436A2 (hu) 2001-11-28
EP1069900B1 (de) 2005-08-10
HUP0102436A3 (en) 2002-01-28
NZ507398A (en) 2004-01-30
DE69926616T2 (de) 2006-05-24
CA2321157A1 (en) 1999-10-21
AU756373B2 (en) 2003-01-09
CZ20003671A3 (en) 2001-06-13
ZA200004454B (en) 2002-04-24
JP2002511414A (ja) 2002-04-16
IL138855A0 (en) 2001-10-31
CA2634698A1 (en) 1999-10-21
EP1069900A1 (de) 2001-01-24
NO20005059L (no) 2000-10-06
WO1999052531A1 (en) 1999-10-21
ES2244189T3 (es) 2005-12-01
ATE301462T1 (de) 2005-08-15
PT1069900E (pt) 2005-10-31
CZ297346B6 (cs) 2006-11-15
BR9909478A (pt) 2000-12-19
AU3449499A (en) 1999-11-01
EA200001049A1 (ru) 2001-04-23
CN1301164A (zh) 2001-06-27
NO20005059D0 (no) 2000-10-06
KR20010034758A (ko) 2001-04-25
DK1069900T3 (da) 2005-10-31
SK14492000A3 (sk) 2001-06-11
TR200002868T2 (tr) 2001-01-22
US6352986B1 (en) 2002-03-05
PL193797B1 (pl) 2007-03-30

Similar Documents

Publication Publication Date Title
MY127739A (en) Use of pramipexole for the treatment of addictive disorders
DE69926616D1 (de) Verwendung von reboxetine zur behandlung neuropsychiatrischer beschwerden
YU71901A (sh) NOVE VRSTE LEKOVITIH KOMPOZICIJA NA BAZI JEDINJENJA KOJA DELUJU ANTIHOLINERGIJSKI I beta-MIMETIKA
BR0205722A (pt) Formulação de liberação prolongada e método para o tratamento de um paciente que sofre de dor
TW329387B (en) Pharmaceutical composition for treating airway passage and lung diseases comprising mometasone furoate
ATE355374T1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
RU94040387A (ru) Композиция, способствующая прекращению курения, никотиносодержащий распыляемый раствор, способ снижения потребности в курении табака, способ замены курения табака
DE60316779D1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
SG167657A1 (en) Novel medicament compositions based on tiotropium salts and on salmeterol salts
DK0796103T3 (da) Anvendelse af røgelse til behandling af Alzheimer-sygdommen
DE69725879D1 (de) VERWENDUNG VON p-AMINOPHENOLDERIVATEN ZUR HERSTELLUNG VON PHARMAZEUTISCHEN ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON NEURODEGENERATIVEN ERKRANKUNGEN
ATE366107T1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
DK1202727T3 (da) Anvendelse af agonister af GABAB-receptorer og farmaceutisk acceptable derivater deraf til behandling for at opnå fortsat nikotinafholdenhed hos nikotinafhængige patienter
ATE319473T1 (de) Melagatran zur behandlung von entzündungen
BR9506748A (pt) Compostos preparação farmacêutica utilização de um composto e processos para o tratamento de um indivíduo sofrendo de dor e para a preparação de um composto
BR9913982A (pt) Derivado de piridil-4h-1,2,4-oxadiazina opticamente ativo e seu uso no tratamento de doenças vasculares
EA200300271A1 (ru) Соединения для лечения расстройств, связанных с зависимостью
ATE331523T1 (de) Statin-therapie zur verbesserung der aufrechterhaltung der kognitiven funktion
ATE341323T1 (de) Verwendung von darifenacin zur behandlung des harndrangs
DE60121978D1 (de) 7-CHLOR-4-HYDROXY-2-(2-PYRIDYLETHYL)-1,2,5,10-TETRAHYDROPYRIDAZINOi4,5-BöCHINOLIN-1,10-DIONE UND IHRE VERWENDUNG ZUR BEHANDLUNG VON SCHMERZEN
DE60122764D1 (de) Verwendung von cortisol-sequestriermitteln zur behandlung von hypercortisolaemie-verwandten erkrankungen
DE69910242D1 (de) Verwendung eines Nikotin-Rezeptor Agonisten zur Herstellung eines Medikaments zur Behandlung von Zwangsneurosen
ATE219675T1 (de) Pharmazeutische zubereitung zur behandlung sogenannter rastloser beine
DE60003921D1 (de) Diphenyl-1,2,3-thiadiazol-3-oxide, zusammensetzungen und verfahren zur anwendung
UA41558A (uk) Лікарський засіб для лікування ран "поліфен"

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee